Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Tampa, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Nextech, an award-winning technology partner for specialty practices and med spas, announced today it has been recognized in the 2026 Best in KLAS®...
-
SHANGHAI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Headquartered in Shanghai, Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic company, announced that it has entered into an agreement...
-
LONDON and NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
-
LONDON and NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
-
Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Persistent Epithelial Defect Market - A Global and Regional Analysis: Focus on End User and Region, 2025-2035" has been added to ...
-
Tampa, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Specialty-specific clinical documentation requires more than a generic, automated note taker to truly improve the charting process. Today, Nextech – an...
-
Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology EMR Software Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Ophthalmology EMR Software...
-
Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
-
ALISO VIEJO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational...
-
BVI appoints Jim Hollingshead as President & CEO, succeeding Shervin Korangy, to lead the company’s next phase of global growth and innovation.